In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Ramy Younes, corporate vice president, global head of ...

An analysis by pharma trade body EFPIA has found "widening equality" in the access to new medicines across 36 European countries that could be compounded by the introduction of the Most Favoured ...

The US Supreme Court has rejected lawsuits from pharma groups challenging Medicare's drug pricing negotiation powers, saying it will not even hear their arguments. The decision appears to draw a line ...

Lead TroFuse-005 investigator Dr Domenica Lorusso of Humanitas University and Humanitas San Pio X in Milan, Italy. MSD's TROP2-targeting antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...

Novartis has reported new data to support its drive to expand the label of its radioligand therapy Pluvicto to include ...

Germany's Merck KGaA is looking at making further acquisitions to boost its business, according to chief executive Belén Garijo. The CEO – who is due to step down next April after five years in the ...

As deaths from an Ebola virus outbreak in the Democratic Republic of Congo and Uganda have risen above 80, the World Health ...

The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...

The turmoil at the FDA continues with the news that Tracy Beth Høeg has been fired as acting head of the FDA's Center for ...

Regeneron has reported that its fianlimab antibody targeting LAG-3, an immune checkpoint proposed as a cancer target, has missed the mark in a highly anticipated melanoma trial. The phase 3 trial was ...

Yet, tell the council you’ve moved and you may still need to inform the school, your GP, the DVLA, and a range of other ...

Lawmakers in the EU have reached a provisional agreement to strengthen the bloc's critical medicine supply chain and avert ...